Literature DB >> 12490380

The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: a suggested mechanism of action.

P Loan Honeywell-Nguyen1, Joke A Bouwstra.   

Abstract

This paper reports the in vitro transport of pergolide from L-595-PEG-8-L elastic vesicle formulations. Several aspects of vesicular delivery were studied in order to elucidate the possible mechanisms of action and to establish the optimal conditions and drug candidates for usage with L-595-PEG-8-L elastic vesicles. All studies were performed using human skin and flow-through Franz diffusion cells. Pergolide was chosen as model drug. The findings show that there was a strong correlation between the drug incorporation to saturated levels and the drug transport, both of which were influenced by the pH of the drug-vesicular system. The optimal pH was found to be 5.0, giving the highest drug incorporation as well as the highest drug transport. Non-occlusive co-treatment with elastic vesicles improved the skin delivery of pergolide compared to the non-occlusive buffer control by more than 2-fold. However, non-occlusive pre-treatment of skin with empty vesicles did not enhance drug transport. Occlusion improved drug transport from both elastic vesicle as well as buffer solutions due to the fact that water is an excellent penetration enhancer for pergolide. However, in contrast to non-occlusive application, the action of the elastic vesicles themselves was diminished, as occlusive treatments with elastic vesicles showed a lower flux compared to occlusive treatment with the buffer control. Hence, the highest pergolide skin permeation in this study was obtained from an occluded saturated buffer solution, giving a steady-state flux of 137.9 ng/h cm(-2). The volume of application did not have any effect on the drug transport. In conclusion, these results showed no evidence that a penetration enhancing effect is the main mechanism of action. The pH of the drug-vesicular system is an important factor to consider when optimising elastic vesicle delivery systems. Occlusion reduces the actions of elastic vesicles, but could increase the pergolide transport since water is a good penetration enhancer for this particular drug. Based on the results obtained, a mechanism of action for the elastic vesicles was proposed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12490380     DOI: 10.1016/s0168-3659(02)00415-7

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  17 in total

1.  Proultraflexible lipid vesicles for effective transdermal delivery of levonorgestrel: development, characterization, and performance evaluation.

Authors:  Subheet Jain; Rachna Sapre; Ashok K Tiwary; Narendra K Jain
Journal:  AAPS PharmSciTech       Date:  2005-10-24       Impact factor: 3.246

2.  Lipid Vesicles for the Skin Delivery of Diclofenac: Cerosomes vs. Other Lipid Suspensions.

Authors:  Anahita Fathi-Azarbayjani; Kai Xin Ng; Yew Weng Chan; Sui Yung Chan
Journal:  Adv Pharm Bull       Date:  2015-03-05

3.  Effect of surfactant mixtures on skin structure and barrier properties.

Authors:  Monica A James-Smith; Brittney Hellner; Nancy Annunziato; Samir Mitragotri
Journal:  Ann Biomed Eng       Date:  2010-11-10       Impact factor: 3.934

Review 4.  Beneath the Skin: A Review of Current Trends and Future Prospects of Transdermal Drug Delivery Systems.

Authors:  Ahlam Zaid Alkilani; Jehad Nasereddin; Rania Hamed; Sukaina Nimrawi; Ghaid Hussein; Hadeel Abo-Zour; Ryan F Donnelly
Journal:  Pharmaceutics       Date:  2022-05-28       Impact factor: 6.525

5.  Enhanced transdermal delivery of salbutamol sulfate via ethosomes.

Authors:  Ehab R Bendas; Mina I Tadros
Journal:  AAPS PharmSciTech       Date:  2007-12-14       Impact factor: 3.246

6.  Skin penetration and mechanisms of action in the delivery of the D2-agonist rotigotine from surfactant-based elastic vesicle formulations.

Authors:  P Loan Honeywell-Nguyen; Sonia Arenja; Joke A Bouwstra
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

7.  Influence of the flexible liposomes on the skin deposition of a hydrophilic model drug, carboxyfluorescein: dependency on their composition.

Authors:  Mohamed Badran; Khaled Shalaby; Abdullah Al-Omrani
Journal:  ScientificWorldJournal       Date:  2012-03-12

Review 8.  Nanoparticles for transcutaneous vaccination.

Authors:  Steffi Hansen; Claus-Michael Lehr
Journal:  Microb Biotechnol       Date:  2011-08-19       Impact factor: 5.813

9.  Preparation and formulation of transferosomes containing an antifungal agent for transdermal delivery: Application of Plackett-Burman design to identify significant factors influencing vesicle size.

Authors:  Rutu B Patel; R H Parikh
Journal:  J Pharm Bioallied Sci       Date:  2012-03

Review 10.  Highly deformable and highly fluid vesicles as potential drug delivery systems: theoretical and practical considerations.

Authors:  Eder Lilia Romero; Maria Jose Morilla
Journal:  Int J Nanomedicine       Date:  2013-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.